ES2654906T3 - Método para determinar la cantidad total y/o la concentración de un analito en presencia de una molécula ligante, así como kits, composiciones y usos relacionados con el mismo - Google Patents

Método para determinar la cantidad total y/o la concentración de un analito en presencia de una molécula ligante, así como kits, composiciones y usos relacionados con el mismo Download PDF

Info

Publication number
ES2654906T3
ES2654906T3 ES14792817.0T ES14792817T ES2654906T3 ES 2654906 T3 ES2654906 T3 ES 2654906T3 ES 14792817 T ES14792817 T ES 14792817T ES 2654906 T3 ES2654906 T3 ES 2654906T3
Authority
ES
Spain
Prior art keywords
analyte
molecule
binding
concentration
binding molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14792817.0T
Other languages
English (en)
Spanish (es)
Other versions
ES2654906T8 (es
Inventor
Michael Schraeml
Markus Roessler
Michael Gerg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Original Assignee
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG, Roche Diagnostics GmbH filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2654906T3 publication Critical patent/ES2654906T3/es
Publication of ES2654906T8 publication Critical patent/ES2654906T8/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ES14792817.0T 2013-11-05 2014-11-03 Método para determinar la cantidad total y/o la concentración de un analito en presencia de una molécula ligante, así como kits, composiciones y usos relacionados con el mismo Active ES2654906T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP13005218 2013-11-05
EP13005218 2013-11-05
EP14002015 2014-06-11
EP14002015 2014-06-11
PCT/EP2014/073523 WO2015067547A1 (en) 2013-11-05 2014-11-03 A method for determining the total amount and/or concentration of an analyte in the presence of a binding molecule as well as kits, compositions and uses relating thereto

Publications (2)

Publication Number Publication Date
ES2654906T3 true ES2654906T3 (es) 2018-02-15
ES2654906T8 ES2654906T8 (es) 2018-02-26

Family

ID=51845410

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14792817.0T Active ES2654906T3 (es) 2013-11-05 2014-11-03 Método para determinar la cantidad total y/o la concentración de un analito en presencia de una molécula ligante, así como kits, composiciones y usos relacionados con el mismo

Country Status (7)

Country Link
US (2) US10564151B2 (https=)
EP (1) EP3066469B1 (https=)
JP (1) JP6446044B2 (https=)
CN (1) CN105683755B (https=)
CA (1) CA2926306C (https=)
ES (1) ES2654906T3 (https=)
WO (1) WO2015067547A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180299436A1 (en) * 2017-01-20 2018-10-18 Shenzhen New Industries Biomedical Engineering Co., Ltd. A method, kit and system for preparing an antibody pair and the use of the kit
WO2024158727A2 (en) * 2023-01-24 2024-08-02 University Of Cincinnati Depletion-limited analyte sensing with non-equilibrium binding probes

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
DE4214922C2 (de) 1992-05-06 1996-06-13 Brahms Diagnostica Gmbh Verfahren zur quantitativen Bestimmung des Anteils der freien Form eines Schilddrüsenhormon-Liganden in einer biologischen Flüssigkeit und Kit zur Durchführung eines solchen Verfahrens
US5312730A (en) 1992-05-27 1994-05-17 Ciba Corning Diagnostics Corp. Immune complex transfer with lypophilic bridge
JPH10513260A (ja) * 1995-01-31 1998-12-15 ノボ ノルディスク アクティーゼルスカブ 前臨床的に糖尿病を診断する方法
US6838250B2 (en) 2000-03-31 2005-01-04 Ortho-Clinical Diagnostics, Inc. Immunoassay for C-reactive protein
CA2535804A1 (en) * 2003-08-14 2005-03-03 Wyeth Anti-lewis y anti-idiotypic antibodies and uses thereof
MXPA06011824A (es) * 2004-04-16 2006-12-15 Genentech Inc Ensayo para anticuerpos.
EP1861708A2 (en) * 2005-03-08 2007-12-05 Tanox, Inc. Methods for determining the bivalency of protein and antibody therapeutics
US20090246795A1 (en) 2005-12-22 2009-10-01 Rohm Co., Ltd. Immunoassay device and method
EP1801594A1 (en) * 2005-12-23 2007-06-27 Koninklijke Philips Electronics N.V. Sensing device and method for determination of the amount of target molecule in an analyte
US20080127359A1 (en) * 2006-11-06 2008-05-29 Hermann Beck Method for producing anti-idiotypic antibodies
TWI434855B (zh) * 2006-11-21 2014-04-21 Hoffmann La Roche 結合物及其在免疫分析中作為參考標準之用途
MX2010002269A (es) 2007-08-28 2010-03-25 Abbott Biotech Ltd Composiciones y metodos que comprenden proteinas de union para adalimumab.
FR2980271B1 (fr) * 2011-09-16 2013-10-11 Cisbio Bioassays Procede de determination de la glycosylation d'un anticorps
CA2853917A1 (en) * 2011-12-19 2013-06-27 F. Hoffmann-La Roche Ag Method for the detection of free binding partner of a multispecific binder
JP2015507193A (ja) * 2012-02-01 2015-03-05 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 多重特異性結合物の結合パートナーを検出するための方法
MX346146B (es) * 2012-07-13 2017-03-09 Hoffmann La Roche Metodo para detectar un aglutinante multiespecifico.
PH12021552742A1 (en) * 2013-08-01 2022-05-23 Five Prime Therapeutics Inc Afucosylated anti-fgfr2iiib antibodies

Also Published As

Publication number Publication date
JP2016535266A (ja) 2016-11-10
HK1225799A1 (zh) 2017-09-15
EP3066469B1 (en) 2017-10-11
JP6446044B2 (ja) 2018-12-26
EP3066469A1 (en) 2016-09-14
CA2926306A1 (en) 2015-05-14
US20200141930A1 (en) 2020-05-07
US10564151B2 (en) 2020-02-18
ES2654906T8 (es) 2018-02-26
CN105683755A (zh) 2016-06-15
WO2015067547A1 (en) 2015-05-14
US12158466B2 (en) 2024-12-03
CN105683755B (zh) 2019-08-13
CA2926306C (en) 2022-12-06
US20160252500A1 (en) 2016-09-01

Similar Documents

Publication Publication Date Title
ES2377579T3 (es) Anticuerpos de alta afinidad contra el receptor de IL-6 humano
ES2595981T3 (es) Anticuerpo antiidiotipo contra un anticuerpo contra el péptido beta amiloide
JP6586648B2 (ja) 抗プログルカゴン抗体
US20150111250A1 (en) Methods and compositions for modulating tumor cell activity
RU2018124602A (ru) Новые анти-pd-l1 антитела
US20240247037A1 (en) Glypican epitopes and uses thereof
US20200062832A1 (en) DbpA ANTIBODIES AND USES THEREOF
ES2654906T3 (es) Método para determinar la cantidad total y/o la concentración de un analito en presencia de una molécula ligante, así como kits, composiciones y usos relacionados con el mismo
PT2248826E (pt) Anticorpo dirigido contra pcrv
US20240182556A1 (en) Stem cell factor antibodies and methods of use thereof
JP2008542366A (ja) Ｆｚｄ８モジュレーターを同定する方法および変形性関節症を処置するためのそのようなモジュレーターの使用
CA2916895C (en) Human anti-il-32 antibodies
JP7084057B2 (ja) 新規抗ｐａｄ２抗体
US10577418B2 (en) Monoclonal anti-GPC-1 antibodies and uses thereof
CN102124100B (zh) 特异结合vegf的单克隆抗体及分泌它的杂交瘤细胞系与用途
JP2023553205A (ja) Ｓｔｒｅｐ－ＴａｇＩＩタグに特異的に結合する抗体およびその使用
CN107964045A (zh) 一种人鼠嵌合抗CXCR2全分子IgG及其应用
JP5663137B2 (ja) ミッドカインのｃ−ドメインを認識する抗体
CN118221814A (zh) 一种抗april抗体及其应用
JP6742590B2 (ja) 抗体又はその抗原結合性フラグメント及びハイブリドーマ
KR20240137027A (ko) 항인간 cxcl1 항체
JP2017109965A (ja) 抗膵ポリペプチドモノクローナル抗体
JP6861349B2 (ja) Ｃｄ８１ ｌｅｌ特異的モノクローナル抗体
CN112794913B (zh) 白血病检测试剂盒
CN119306842B (zh) 抗甲基苯丙胺抗体、检测甲基苯丙胺的试剂和试剂盒